FDA.reportPublic FDA data

amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule

RxCUI
2262026
RxNorm name
amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule
Display name
amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule
Full name
amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TaliciaOMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTINRedHill Biopharma Ltd68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f2025-12-23Warnings, Adverse reactionsExact identifier
rxcui: 2262026

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68c4e9dc-dbcf-4151-b6f7-5e4b9922b76famoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [PSN] · amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [SCD]210These highlights do not include all the information needed to use TALICIA ® safely and effectively. See full prescribing information for TALICIA. TALICIA (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules, for oral use Initial U.S. Approval: 201920251223